superDimension Launches Second Generation iLogic(TM)Electromagnetic Navigation Bronchoscopy System to Detect and Diagnose Lung Cancer

superDimension Launches Second Generation iLogic(TM)Electromagnetic Navigation
Bronchoscopy System to Detect and Diagnose Lung Cancer
Technology provides more sophisticated software platform to improve navigation
and positioning

MINNEAPOLIS, Nov. 2 /PRNewswire/ -- superDimension, Inc.®, a private company
that develops minimally invasive interventional pulmonology devices, announced
today the launch of the iLogic System for early lung cancer detection and
diagnosis. The device is the second generation version of inReach(TM),
superDimension's electromagnetic navigation bronchoscopy (ENB) minimally
invasive tool. The core technology for both inReach and iLogic extend beyond
the capabilities of the traditional bronchoscope to distant, previously
inaccessible regions of the lungs, and enables physicians to locate small lung
lesions for diagnostic testing. superDimension debuted the iLogic(TM) system
at the American College of Chest Physicians (CHEST) annual meeting in San
Diego and the American Society for Radiation Oncology (ASTRO) Conference in
Chicago.

Improvements offered by the iLogic include a new software platform with a
simplified positioning and navigational system that improves ease of use and
further enhances visualization for the pulmonologist. The virtual 3-D
bronchial tree made possible with the technology extends deep into the lungs
reaching more than 17 airway generations. Further, the customized
high-definition views available with iLogic offer physicians multiple
navigation perspectives to improve detection and diagnosis. A 26-inch
high-definition wide screen format allows six viewports to be displayed
simultaneously, including one video input, enabling the physician to evaluate
positional data and optimize central and peripheral guidance within the lung.

"We believe the more elegant and simplified iLogic software will surpass the
needs of the pulmonologists who find inReach invaluable for the treatment of
their patients," said Daniel J. Sullivan, president and Chief Executive
Officer. "As medical professionals become more comfortable and familiar with
ENB, we believe the introduction of iLogic will further ignite enthusiasm for
adoption of the system and ultimately, improve patient outcomes."

superDimension is exhibiting at the American College of Chest Physicians
(CHEST) annual meeting in San Diego at booth 819 and the American Society for
Radiation Oncology (ASTRO) Conference in Chicago at booth 3216.

About Lung Cancer
According to the Centers for Disease Control (CDC), "Lung cancer is the
leading cause of cancer deaths in the United States, causing more deaths than
breast cancer, prostate cancer and colon cancer -- the next three deadliest
cancers combined. Each year, approximately 200,000 patients are newly
diagnosed with lung cancer in the United States and an additional 160,000
patients die from the disease." The company notes, this is in addition to the
millions of patients who are currently on watchful waiting with an undiagnosed
spot on their lung.

For more information about lung cancer and its diagnosis, please visit
www.spotonyourlung.com.

About superDimension
superDimension, Inc. is a Minneapolis-based, privately held company that
develops and markets catheter based devices for use in the minimally invasive
diagnosis and treatment of early stage lung cancer and other diseases, using
the patient's natural airways to avoid surgery. For more information, please
visit www.superdimension.com.

COMPANY CONTACTS: Media and Investor Contacts:
----------------- ----------------------------
superDimension, Inc. The Ruth Group
Dan Sullivan Scott Lerman (media)
President and CEO 646-536-7013
763-210-4011 slerman@theruthgroup.com

Rick Buchholz Nick Laudico (investors)
Chief Financial Officer 646-536-7030
763-210-4012 nlaudico@theruthgroup.com

Karen Solie (on site at ASTRO)
Cell: 952-220-9011

SOURCE superDimension, Inc.

Dan Sullivan, President and CEO, +1-763-210-4011, or Rick Buchholz, Chief
Financial Officer, +1-763-210-4012, or Karen Solie, on site at ASTRO, Cell:
+1-952-220-9011, all of superDimension, Inc.; or Media, Scott Lerman,
+1-646-536-7013, slerman@theruthgroup.com, or Investors, Nick Laudico,
+1-646-536-7030, nlaudico@theruthgroup.com, both of The Ruth Group for
superDimension, Inc